Items stated in the management plan
FormulatedEach line is the climb from the baseline the document states to the target it sets. The slope is scaled against the largest climb in this document. For metrics expressed as percentages, differences are shown in percentage points (pt).
| Item | Details |
|---|---|
| Plan name | Growth Plan2027 |
| Plan period | Start year: Not disclosed; final year: fiscal year ending August 2027 |
| Progress against the plan | Formulated |
| ROE target | 9.7% (fiscal year ended August 2026) → 10% or higher |
| Payout ratio / DOE policy | Stable dividends, targeting a consolidated payout ratio of 30%. Covered period: Not disclosed |
| Cost of capital | 8–9% (cost of equity based on CAPM), approximately 9–12% (broad cost of equity calculated as the earnings yield) |
| Self-assessment of PBR and share price | PBR was 0.85x for the fiscal year ending August 2026. Although it has remained around 0.8x since the fiscal year ended August 2023, it is still at a low level. The company aims to achieve a PBR of at least 1x. |
| Key initiatives | ① Business strategy, ② Capital and financial strategy, ③ IR strategy |
Items this document does not state (17)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company identified as challenges the fact that PBR has remained below 1x, ROE has not exceeded the cost of shareholders' equity expected by investors, net income margin is low at approximately 2%, and expectations for medium- to long-term growth strategies and improved profitability are not sufficiently reflected in the share price.